The death receptor Fas (CD95) is differentially expressed in brain metastases in breast cancer.
Breast cancer patients with metastasis to the brain are faced with limited treatment options (1). To facilitate enhanced understanding of the transcriptional makeup of brain metastasis in human breast cancer and to support discovery of novel therapeutic targets, we mined published microarray datasets (2, 3) to identify genes whose expression was most markedly different when comparing brain metastases to primary tumors from patients with breast cancer. We identified the Fas receptor as among the genes whose expression was most significantly different in metastases to the brain as compared to primary tumors of the breast. Decreased expression of Fas in brain metastases in patients with breast cancer may be important for any number of steps involved in metastasis, including colonization of the brain.